Z. Khan, “Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study”, J Cancer Allied Spec, vol. 10, no. 2, Jun. 2024.